Three cases of oral mucosal tuberculosis in patients on <scp>tumour‐necrosis‐factor</scp>‐α blockers-Reference-Cited by-同舟云学术

Three cases of oral mucosal tuberculosis in patients on tumour‐necrosis‐factor‐α blockers

Published:2023-02-06 Issue:2 Volume:64 Page:268-271
ISSN:0004-8380
Container-title:Australasian Journal of Dermatology
language:en
Short-container-title:Aust J Dermatology

Author:

Nico Marcello Menta Simonsen¹^ORCID,Fanciozi Amithis Bernstorff¹,da Costa Álvaro Furtado²,Lourenço Silvia Vanessa³^ORCID

Affiliation:

1. Department of Dermatology Medical School, University of São Paulo São Paulo Brazil

2. Department of Infectious Diseases Medical School, University of São Paulo São Paulo Brazil

3. Department of Pathology Dental School, University of São Paulo São Paulo Brazil

Abstract

AbstractWe present three cases of oral mucosal lesions caused by Mycobacterium tuberculosis in patients treated with anti‐tumour necrosis factor‐α for psoriasis or rheumatoid arthritis. Diagnosis of oral mucosal tuberculosis was not easily established in any of the cases. A comparison between these cases and other previously described forms of oral mucosal tuberculosis is presented.

Publisher

Wiley

Subject

Dermatology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/ajd.13998

Reference8 articles.

1. Tuberculosis and Biologic Therapies

2. Risk of tuberculosis reactivation with interleukin (IL)‐17 and IL‐23 inhibitors in psoriasis – time for a paradigm change

3. Detection and management of latent tuberculosis infections before biologic therapy for psoriasis

4. Risk of tuberculosis with the use of anti-TNF medications in psoriasis: incidence, screening and management

5. Tuberculosis Associated with Infliximab, a Tumor Necrosis Factor α–Neutralizing Agent

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adalimumab/infliximab;Reactions Weekly;2024-07-13